• Ashish Dixit, Tathagat Chatterjee, Pravas Mishra, Meganathan Kannan, Dharma R Choudhry, Manoranjan Mahapatra, V P Choudhry, and Renu Saxena.
• Department of Haematology, All India Institute of Medical Sciences, New Delhi, India.
• Clin. Appl. Thromb. Hemost. 2007 Jul 1; 13 (3): 292-8.

AbstractBetween January 2001 and December 2003, 67 patients with acute leukemia were evaluated prospectively for hemostatic abnormality at presentation, of which 43 (64.2%) had acute lymphoblastic leukemia and 24 (35.8%) had acute myelogenous leukemia. At presentation, 27 patients (40.3%) had bleeding manifestations. Thrombocytopenia was present in 57 patients (85%), and 33(49.3%) had some abnormality of global coagulation markers. Disseminated intravascular coagulation was defined by International Society of Thrombosis and Hemostasis criteria. Disseminated intravascular coagulation was more often associated with bleeding manifestations in acute myelogenous leukemia cases than in acute lymphoblastic leukemia cases. Two patients presented disseminated intravascular coagulation on day 7 of chemotherapy, without any bleeding manifestations. Four of 15 evaluated cases who had a bleeding or infection complication after day 7 of induction therapy also had disseminated intravascular coagulation. It is recommended that all patients with leukemia be investigated for disseminated intravascular coagulation at presentation.

34 keywords...

hide…